-
Forward Look
Common-Sense ScreeningSigmoidoscopy may be a good option for colorectal cancer screening.
by Sue Rochman
-
Forward Look
Task Force Says “No” to PSA for Prostate Cancer ScreeningExpert panel's recommendation spurs debate.
by Stephen Ornes
-
Survivor Profile
Touched by an AngelJonny Imerman is the heart and hub of a network of cancer survivors.
by Pamela Ferdinand
-
Yesterday & Today
A Leading LadyBetty Ford's candor about her breast cancer diagnosis helped bring a private issue out of the shadows.
by Corinna Wu
-
Teaming Up for Better Treatment
Across the country, survivors' opinions and actions are influencing cancer care.
by Stephen Ornes
-
Q&A
Facing the CriticsRoger Ebert finds peace with his appearance following disfiguring cancer surgery.
by Ronni Gordon
-
Get Involved
One Young Survivor Helping AnotherA teen who survived cancer is raising money to help others.
by Yvonne Lee
-
The Survival Gap
In the Nowhere Land between adult and pediatric cancer treatment, young adults face survival rates that have missed out on the gains seen by other age groups. Can new efforts help them improve their outcomes?
by Charlotte Huff
-
Forward Look
Fertility Preservation Catches On, But SlowlyNew cancer patients need information and quick referrals to infertility specialists.
by Charlotte Huff
Cancer Talk
Cancer Vaccines Show Promise in Early Trials
While mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona